Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference
2024年3月12日 - 10:00PM
ビジネスワイヤ（英語）
Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or
“Revelation) a clinical-stage life sciences company that is focused
on harnessing the power of trained immunity for the prevention and
treatment of disease, announced today that its Chief Executive
Officer James Rolke will participate in a virtual fireside chat at
the 36th Annual Roth Conference scheduled for March 17-19, 2023 to
be held at The Ritz Carlton, Laguna Niguel in Dana Point,
California.
Details regarding the Revelation fireside chat are as
follows:
35th Annual Roth Conference Presentation Details
Date:
Monday, March 18, 2023
Time:
11:00 a.m. Pacific Time
Location:
The Ritz Carlton, Laguna Niguel, CA
Webcast:
REVB Webcast Link
A live webcast of the presentation will also be available in the
Investor Relations section of Revelation’s website at
https://www.revbiosciences.com. A replay of the presentation will
be available on Revelation’s website for 30 days following the
event.
Mr. Rolke will be available for one-on-one meetings throughout
the conference in person and virtually.
About Revelation Biosciences Inc.
Revelation Biosciences, Inc. is a life sciences company focused
on harnessing the power of trained immunity for the prevention and
treatment of disease using its proprietary formulation, Gemini.
Revelation has multiple ongoing programs to evaluate Gemini,
including GEMINI-SSI as a prevention for post-surgical infection,
GEMINI-AKI as a prevention for acute kidney injury, and GEMINI-CKD
for the treatment of chronic kidney disease.
For more information on Revelation, please visit
www.RevBiosciences.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240312834070/en/
Sandra Vedrick Vice President, Investor Relations & Human
Resources Revelation Biosciences Inc. Email:
svedrick@revbiosciences.com
and
Chester Zygmont, III Chief Financial Officer Revelation
Biosciences Inc. Email: czygmont@revbiosciences.com
Revelation Biosciences (NASDAQ:REVB)
過去 株価チャート
から 11 2024 まで 12 2024
Revelation Biosciences (NASDAQ:REVB)
過去 株価チャート
から 12 2023 まで 12 2024
